FLASH NEWS LIVE

Piper Sandler Raises AbbVie (ABBV) Price Target to $289, Maintains Overweight Rating

Piper Sandler Raises AbbVie (ABBV) Price Target to $289, Maintains Overweight Rating

AbbVie Inc. (NYSE:ABBV) is included among the 15 Best DRIP Stocks to Own Right Now. On November 5, Piper San‍dler​ analyst David Amsellem raised the price...

Read Full Article →

📱 Tip: Tap the 🔗 Share icon in Safari and choose Add to Home Screen to install World Trade Factory.
Instagram Meta X LinkedIn Whatsapp